Valspodar (Mixture of isomers)

Valspodar (Mixture of isomers),(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone,Valspodar Therapeutic

1 MG

In Stock

5 MG

In Stock

10 MG

In Stock

Stock Status: In Stock

Live

Bulk & Custom R&D

There is no hazardous surcharge associated with this product
There is no packaging charge associated with this product
Strictly for Research Purposes only. Not for Personal or Veterinary use.

CAS No.

[121584-18-7]

Product Code

CS-T-62692

M.F.

C₆₃H₁₁₁N₁₁O₁₂

M.W.

1214.62

Smiles

O=C([C@H](C(C)C)N(C)C([C@H](CC(C)C)N(C)C([C@H](CC(C)C)N(C)C([C@@H](C)NC([C@H](C)NC([C@H](CC(C)C)N(C)C([C@H](C(C)C)NC([C@H](CC(C)C)N(C)C(CN(C)C([C@H](C(C)C)N1)=O)=O)=O)=O)=O)=O)=O)=O)=O)N(C)[C@@H](C([C@H](C)C/C=C/C)=O)C1=O>>O=C([C@H](C(C)C)N(C)C([C@H](CC(C)C)N(C)C([C@H](CC(C)C)N(C)C([C@@H](C)NC([C@H](C)NC([C@H](CC(C)C)N(C)C([C@H](C(C)C)NC([C@H](CC(C)C)N(C)C(CN(C)C([C@H](C(C)C)NC/2=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)N(C)C2=C(O)/[C@H](C)C/C=C/C

Therapeutic Uses

Anti-Cancer / Oncology

Valspodar (Mixture of isomers) is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.

Specification Request Specification

MSDS

Request MSDS

TSE / BSE Statement

TSE-BSE declaration Valspodar (Mixture of isomers) CS-T-62692

Retest Statement

Retest Statement Valspodar (Mixture of isomers) CS-T-62692

Search CoA's by Lot Number or Product Code (Example)

Menu

Valspodar (Mixture of isomers)

Stock Status: In Stock

Specification Request Specification

MSDS

TSE / BSE Statement

Retest Statement